Cardiac Transplantation for Ischemic Heart Disease

Iver, Robroy H. Mac; McCarthy, Patrick M.

doi:10.1007/978-1-84628-712-1_10

Cited by 1 publication

(2 citation statements)

References 99 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although CABG is initially indicated for ICM patients with LV dysfunction and severely depressed LV dysfunction, cardiac transplantation may be considered as an alternative therapy. Further, Mac Iver et al [100] report that for ICM patients with end-stage heart failure and those who do not exhibit any clinical benefit from cardiac revascularization are usually considered for cardiac transplantation. In summary, the main therapeutic target for clinical management of ICM is relieving symptoms and preventing the progression of heart failure.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Ischemic cardiomyopathy: A review of literature on clinical status and meta-analysis of diagnostic and clinical management

Albakri¹

2018

Biol Eng Med

View full text Add to dashboard Cite

Ischemic heart disease is the leading cause of sudden cardiac death. It may lead to cardiomyopathy in the setting of coronary artery disease and gradually progressing to heart failure. While ischemic cardiomyopathy is a well-recognized disease entity, the current classification systems of cardiomyopathy exclude cardiomyopathies secondary to ischemia. Further, research on ischemic cardiomyopathy is extensively fragmented, which has undermined both research consensus and comprehensive understanding. The fragmentation is attributable to its variable terminologies (ischemic heart disease or its three leading non-fatal sequela -angina pectoris, acute myocardial infarction and ischemic heart failure). Therefore, the purpose of the present review is to accumulate research on ischemic cardiomyopathy to produce a comprehensive understanding of its clinical status, diagnosis, clinical management and improve survival.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Although CABG is highly recommended to these patients as an alternative chronic treatment for cardiac transplantation [98,99], patients with end-stage ICM with no evidence of viability do not benefit from revascularization. [100].…”

Section: Cardiac Transplantationmentioning

confidence: 99%

Ischemic cardiomyopathy: A review of literature on clinical status and meta-analysis of diagnostic and clinical management

Albakri¹

2018

Biol Eng Med

View full text Add to dashboard Cite

show abstract

Cardiac Transplantation for Ischemic Heart Disease

Cited by 1 publication

References 99 publications

Ischemic cardiomyopathy: A review of literature on clinical status and meta-analysis of diagnostic and clinical management

Ischemic cardiomyopathy: A review of literature on clinical status and meta-analysis of diagnostic and clinical management

Contact Info

Product

Resources

About